Table 1.
Baseline Characteristics in the Overall Sample (n=3024), Stratified by Blood Pressure Group
| Characteristics | Overall Sample (N=3024) | |||||
|---|---|---|---|---|---|---|
| Group 1, <120/80 mm Hg, No Treatment (n=909) | Group 2, ≥120/80 to <140/90 mm Hg, No Treatment (n=970) | Group 3, <140/90 mm Hg, On Treatment (n=393) | Group 4, ≥140/90 mm Hg, No Treatment (n=413) | Group 5, ≥140/90 mm Hg, On Treatment (n=339) | P trend | |
| Clinical and biochemical features | ||||||
| Age, y, mean±SD | 53.7±8.8 | 57.9±9.1 | 61.0±8.5 | 61.4±9.1 | 65.7±8.1 | <0.0001 |
| Women, n (%) | 582 (64.0) | 503 (51.9) | 201 (51.2) | 211 (51.1) | 178 (52.5) | <0.0001 |
| SBP, mm Hg, mean±SD | 109±7 | 127±7 | 125±10 | 152±13 | 154±14 | <0.0001 |
| DBP, mm Hg; mean±SD | 68±6 | 77±7 | 75±8 | 84±10 | 82±10 | <0.0001 |
| Hypertension treatment, n (%) | 0 (0.0) | 0 (0.0) | 393 (100.0) | 0 (0) | 339 (100.0) | <0.0001 |
| BMI, kg/m² | 26.1±4.4 | 27.9±5.0 | 29.8±5.8 | 28.4±5.4 | 29.3±5.3 | <0.0001 |
| Smoking, n (%) | 165 (18.2) | 139 (14.3) | 39 (9.9) | 65 (15.8) | 32 (9.4) | 0.0004 |
| Diabetes, n (%) | 21 (2.3) | 52 (5.4) | 62 (15.8) | 32 (7.8) | 61 (18.0) | <0.0001 |
| Total cholesterol, mg/dL, mean±SD | 200±37 | 209±38 | 203±34 | 214±39 | 207±36 | <0.0001 |
| HDL cholesterol, mg/dL, mean±SD | 54±16 | 52±16 | 49±16 | 52±17 | 50±16 | <0.0001 |
DBP indicates diastolic blood pressure; HDL, high‐density lipoprotein; SBP, systolic blood pressure.